Llovet JM - Search Results

1

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment.

Llovet JM, Willoughby CE, Singal AG, Greten TF, Heikenwälder M, El-Serag HB, Finn RS, Friedman SL. Llovet JM, et al. Nat Rev Gastroenterol Hepatol. 2023 Aug;20(8):487-503. doi: 10.1038/s41575-023-00754-7. Epub 2023 Mar 17. Nat Rev Gastroenterol Hepatol. 2023. PMID: 36932227 Review.

2

Prognosis of hepatocellular carcinoma.

Llovet JM, Fuster J, Bruix J. Llovet JM, et al. Hepatogastroenterology. 2002 Jan-Feb;49(43):7-11. Hepatogastroenterology. 2002. PMID: 11941987 Review.

3

Evidence-based medicine in the treatment of hepatocellular carcinoma.

Llovet JM. Llovet JM. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S428-33. doi: 10.1046/j.1440-1746.17.s3.40.x. J Gastroenterol Hepatol. 2002. PMID: 12472976 Review.

4

Treatment of hepatocellular carcinoma: is there an optimal strategy?

Varela M, Sala M, Llovet JM, Bruix J. Varela M, et al. Among authors: llovet jm. Cancer Treat Rev. 2003 Apr;29(2):99-104. doi: 10.1016/s0305-7372(02)00123-8. Cancer Treat Rev. 2003. PMID: 12670452 Review.

5

p27(Kip1) is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma.

Armengol C, Boix L, Bachs O, Solé M, Fuster J, Sala M, Llovet JM, Rodés J, Bruix J. Armengol C, et al. Among authors: llovet jm. J Hepatol. 2003 May;38(5):591-7. doi: 10.1016/s0168-8278(03)00025-4. J Hepatol. 2003. PMID: 12713869

6

Non-surgical therapies of hepatocellular carcinoma.

Llovet JM, Sala M. Llovet JM, et al. Eur J Gastroenterol Hepatol. 2005 May;17(5):505-13. doi: 10.1097/00042737-200505000-00006. Eur J Gastroenterol Hepatol. 2005. PMID: 15827440 Review.

7

Updated treatment approach to hepatocellular carcinoma.

Llovet JM. Llovet JM. J Gastroenterol. 2005 Mar;40(3):225-35. doi: 10.1007/s00535-005-1566-3. J Gastroenterol. 2005. PMID: 15830281 Review.

8

Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling.

Lemmer ER, Friedman SL, Llovet JM. Lemmer ER, et al. Among authors: llovet jm. Semin Liver Dis. 2006 Nov;26(4):373-84. doi: 10.1055/s-2006-951604. Semin Liver Dis. 2006. PMID: 17051451 Review.

9

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL. Llovet JM, et al. Gastroenterology. 2006 Dec;131(6):1758-67. doi: 10.1053/j.gastro.2006.09.014. Epub 2006 Sep 19. Gastroenterology. 2006. PMID: 17087938

10

Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.

Kremer-Tal S, Narla G, Chen Y, Hod E, DiFeo A, Yea S, Lee JS, Schwartz M, Thung SN, Fiel IM, Banck M, Zimran E, Thorgeirsson SS, Mazzaferro V, Bruix J, Martignetti JA, Llovet JM, Friedman SL. Kremer-Tal S, et al. Among authors: llovet jm. J Hepatol. 2007 Apr;46(4):645-54. doi: 10.1016/j.jhep.2006.10.012. Epub 2006 Nov 27. J Hepatol. 2007. PMID: 17196295 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

341 results

Search Page